← Leaderboards
Raghu S Pandurangi
Sci-Engi-Medco Solutions, Inc.
$223,963
Attributed
$539,410
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $274.5K · FY2014–17$500K$375K$250K$125K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$539,410 · 2
By mechanism
R43$539,410 · 2
Top collaborators
- Ramasamy Paulmurugan2 shared
- Kathleen Louise Gabrielson1 shared
- Martin G Pomper1 shared
Others in their field
Top investigators on “Laboratories”
- David Heimbrook · Leidos Biomedical Research, Inc.$943,075,715
- Lawrence Corey · Fred Hutchinson Cancer Center$747,603,944
- Jeffrey P Krischer · University Of South Florida$627,303,958
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$553,634,937
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
Research focus
LaboratoriesProstateDoxorubicinKidneyNeoplastic CellPharmaceutical PreparationsChemotherapyDoseGemcitabineIn VivoCell DeathMalignant NeoplasmsBasePathway InteractionsCarboplatinBiologicalCancer CellClinical ResearchApoptosisFundingAnimal ModelIn VitroBreastResistance
Grant awards (3)
Theranostics of Reduction of Cardiotoxicity Using Targeted Apoptosis Activation Technology$274,452
R43 · FY2017 · CA · contact PI
AAAPT Technology for Improving Chemotherapy$40,000
R43 · FY2016 · CA · contact PI
Dual Targeted Human Beta Defensin for Improving Chemotherapy$224,958
R43 · FY2014 · CA · contact PI